2seventy bio, Inc.
TSVT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $153,521 | $210,409 | $333,919 | $604,484 |
| - Cash | $71,244 | $74,958 | $71,032 | $130,414 |
| + Debt | $243,717 | $256,673 | $270,172 | $282,215 |
| Enterprise Value | $325,994 | $392,124 | $533,059 | $756,285 |
| Revenue | $37,862 | $100,387 | $91,496 | $54,522 |
| % Growth | -62.3% | 9.7% | 67.8% | – |
| Gross Profit | $15,299 | $83,469 | $65,277 | $41,934 |
| % Margin | 40.4% | 83.1% | 71.3% | 76.9% |
| EBITDA | -$98,446 | -$206,418 | -$251,375 | -$297,159 |
| % Margin | -260% | -205.6% | -274.7% | -545% |
| Net Income | -$57,247 | -$217,570 | -$254,144 | -$276,214 |
| % Margin | -151.2% | -216.7% | -277.8% | -506.6% |
| EPS Diluted | -1.1 | -4.42 | -7.13 | -11.71 |
| % Growth | 75.1% | 38% | 39.1% | – |
| Operating Cash Flow | -$84,998 | -$166,858 | -$237,134 | -$207,034 |
| Capital Expenditures | -$707 | -$13,865 | -$22,842 | -$19,575 |
| Free Cash Flow | -$85,705 | -$180,723 | -$259,976 | -$226,609 |